Drries patent opposition analysis

The comprehensive analysis of Drries opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Drries

Patent NumberTitleApplicantOpposition DateOpposition Company
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DRRIES
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DRRIES
Mutated Glycoprotein Of Vesicular Stomatitis VirusCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSMay 14, 2025DRRIES
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSJan 15, 2025DRRIES
Methods For Treating Skin Infection By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYNov 13, 2024DRRIES
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 7, 2024DRRIES
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit InhibitorsF HOFFMANN LA ROCHEApr 7, 2021DR H ULRICH DRRIES
Combination Therapy For The Treatment Of GlioblastomaF HOFFMANN LA ROCHEJul 9, 2019DRRIES
Methods Of Cell CultureMOMENTA PHARMACEUTICALSJun 19, 2019DRRIES

Top companies who are the clients of Drries